Browse > Article
http://dx.doi.org/10.3345/kjp.2019.01116

Strategies for treating and managing chronic hepatitis C in children in the direct-acting antiviral era  

Hong, Suk-Jin (Department of Pediatrics, School of Medicine, Daegu Catholic University)
Choe, Byung-Ho (Department of Pediatrics, School of Medicine, Kyungpook National University)
Publication Information
Clinical and Experimental Pediatrics / v.63, no.2, 2020 , pp. 46-47 More about this Journal
Keywords
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 World Health Organization. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection [Internet]. Geneva (Switzerland): World Health Organization; 2018 [cited 2019 Sep 15]. Available from: https://www.who.int/hepatitis/publications/hepatitisc-guidelines-2018.
2 Kim BK, Jang ES, Kim JH, Park SY, Ahn SV, Kim HJ, et al. Current status of and strategies for hepatitis C control in South Korea. Clin Mol Hepatol 2017;23:212-8.   DOI
3 Indolfi G, Serranti D, Resti M. Direct-acting antivirals for children and adolescents with chronic hepatitis C. Lancet Child Adolesc Health 2018;2:298-304.   DOI
4 Wirth S, Ribes-Koninckx C, Calzado MA, Bortolotti F, Zancan L, Jara P, et al. High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. J Hepatol 2010;52:501-7.   DOI
5 Rashed YK, Khalaf FA, Kotb SE. Thyroid disturbances in children treated with combined Pegylated Interferon alpha and Ribavirin for chronic hepatitis C. Clin Exp Pediatr 2020;63:52-5.   DOI
6 Mandac JC, Chaudhry S, Sherman KE, Tomer Y. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology 2006;43:661-72.   DOI
7 Hwang Y, Kim W, Kwon SY, Yu HM, Kim JH, Choe WH. Incidence of and risk factors for thyroid dysfunction during peginterferon ${\alpha}$ and ribavirin treatment in patients with chronic hepatitis C. Korean J Intern Med 2015;30:792-800.   DOI
8 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2018. J Hepatol 2018;69:461-511.   DOI
9 The American Association for the Study of Liver Diseases, the Infectious Diseases Society of America. HCV guidance: recommendations for testing, managing, and treating hepatitis C [Internet]. AASLD, IDSA;[cited 2019 Sep 14]. Available from: https://www.hcvguidelines.org.